MedTrace Logo

ALLiance for sEcondary PREvention After an Episode of Acute Coronary Syndrome (ALLEPRE)

NCT02522182 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2060

Last updated 2025-03-26

No results posted yet for this study

Summary

The purpose of the ALLEPRE trial is to compare the benefit offered by a structured, intensive and fully nurse-led intensive secondary prevention intervention programme with that offered by standard of care in a high-risk population of patients admitted to hospital because of an ACS.

Conditions

  • Acute Coronary Syndrome

Interventions

BEHAVIORAL

Nurse-led Intensive Secondary Prevention Programme

Information related to intervention description have been already included in arm/group description

BEHAVIORAL

Usual Treatment

Information related to intervention description have been already included in arm/group description

Sponsors & Collaborators

  • Azienda Ospedaliero-Universitaria di Parma

    lead OTHER

Principal Investigators

  • Diego Ardissino, MD · Azienda Ospedaliero-Universitaria di Parma

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2025-01-31
Completion
2025-01-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02522182 on ClinicalTrials.gov